Shore Paul M, Jackson Edwin K, Wisniewski Stephen R, Clark Robert S B, Adelson P David, Kochanek Patrick M
Department of Critical Care Medicine, University of Pittsburgh School of Medicine and Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA.
Neurosurgery. 2004 Mar;54(3):605-11; discussion 611-2. doi: 10.1227/01.neu.0000108642.88724.db.
Vascular endothelial growth factor (VEGF) is an important regulator of angiogenesis, the formation of which is triggered by hypoxia, cytokines, and growth factors and is also induced by activation of the adenosine 2B receptor. VEGF is neuroprotective in several models of experimental brain injury and is increased in brain after traumatic brain injury (TBI) in humans and experimental animals. Adenosine is a neuroprotective purine metabolite that increases in cerebrospinal fluid (CSF) after clinical TBI in children. We hypothesized that VEGF levels would 1). be increased in CSF after TBI in infants and children, and 2). be preceded by increases in CSF adenosine. To test this hypothesis, we designed a case-control study to compare the CSF of infants and children after severe TBI with that of uninjured children.
Using an Institutional Review Board-approved protocol, we compared CSF concentrations of VEGF (by enzyme-linked immunosorbent assay) and adenosine (by high-performance liquid chromatography) in 73 samples from 14 infants and children with severe TBI (Glasgow Coma Scale score <or=8) with those in CSF from 5 noninjured control subjects. Patients received standard neurointensive care.
Mean VEGF levels were increased after TBI versus control (39.8 +/- 6.2 versus 14.9 +/- 1.5 ng/dl, mean +/- standard error of the mean, P = 0.0002) and peaked at 91.6 +/- 26.4 ng/dl, approximately 6 times control (P = 0.001). Peak VEGF occurred at 22.4 hours after injury. There was a trend toward increased adenosine concentration after TBI versus control (18.3 +/- 3.5 versus 11.5 +/- 2.3 nmol/L), but this did not reach statistical significance. A multivariate regression model showed an independent, significant association between the concentrations of VEGF and adenosine.
VEGF is increased in CSF after pediatric TBI, and this increase is associated with an increase in CSF adenosine. These results may imply that a component of the vascular regenerative response of the brain is initiated rapidly after TBI and continues for several days after injury. Further investigation is warranted to determine 1). whether this association is causative, 2). the role of adenosine in triggering the increase in CSF VEGF concentration, and 3). the exact role VEGF that plays after injury.
血管内皮生长因子(VEGF)是血管生成的重要调节因子,血管生成由缺氧、细胞因子和生长因子触发,也可由腺苷2B受体激活诱导。在几种实验性脑损伤模型中,VEGF具有神经保护作用,在人类和实验动物的创伤性脑损伤(TBI)后,脑内VEGF水平会升高。腺苷是一种具有神经保护作用的嘌呤代谢产物,在儿童临床TBI后脑脊液(CSF)中含量会升高。我们假设VEGF水平会:1)在婴幼儿和儿童TBI后脑脊液中升高;2)在脑脊液腺苷升高之前升高。为验证这一假设,我们设计了一项病例对照研究,比较重度TBI婴幼儿和儿童的脑脊液与未受伤儿童的脑脊液。
采用经机构审查委员会批准的方案,我们通过酶联免疫吸附测定法比较了14例重度TBI婴幼儿和儿童(格拉斯哥昏迷量表评分≤8分)的73份脑脊液样本中VEGF的浓度,并通过高效液相色谱法比较了其中腺苷的浓度,与5名未受伤对照受试者的脑脊液进行对比。患者接受标准的神经重症监护。
与对照组相比,TBI后VEGF平均水平升高(39.8±6.2对14.9±1.5 ng/dl,平均值±平均标准误差,P = 0.0002),峰值达到91.6±26.4 ng/dl,约为对照组的6倍(P = 0.001)。VEGF峰值出现在受伤后22.4小时。与对照组相比,TBI后腺苷浓度有升高趋势(18.3±3.5对11.5±2.3 nmol/L),但未达到统计学意义。多变量回归模型显示VEGF和腺苷浓度之间存在独立、显著的关联。
小儿TBI后脑脊液中VEGF升高,且这种升高与脑脊液中腺苷升高有关。这些结果可能意味着脑的血管再生反应的一个组成部分在TBI后迅速启动,并在损伤后持续数天。有必要进一步研究以确定:1)这种关联是否具有因果关系;2)腺苷在触发脑脊液VEGF浓度升高中的作用;3)VEGF在损伤后的确切作用。